We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Regional Management Corp
RM
$303M
| $870K | ﹤0.01% |
31,005
-176,627
| -85% | -$6.42M |
|
2777
IES Holdings
IESC
$15.2B
| $860K | ﹤0.01% |
31,140
-77
| -0.2% | -$2.38K |
|
2778
Parke Bancorp
PKBK
$405M
| $856K | ﹤0.01% |
40,821
+17
| +0% | +$376 |
|
2779
Sierra Bancorp
BSRR
$525M
| $855K | ﹤0.01% |
43,292
-1,778
| -4% | -$38.1K |
|
|
ENFN
2780
DELISTED
Enfusion, Inc.
ENFN
| $854K | ﹤0.01% |
69,155
+1,395
| +2% | +$17K |
|
2781
Lands' End
LE
$403M
| $853K | ﹤0.01% |
110,439
-1,852
| -2% | -$22.8K |
|
2782
Blue Ridge Bankshares
BRBS
$332M
| $852K | ﹤0.01% |
66,995
-968
| -1% | -$14K |
|
2783
Park Aerospace
PKE
$819M
| $852K | ﹤0.01% |
77,168
-1,831
| -2% | -$21.6K |
|
|
CMRX
2784
DELISTED
Chimerix, Inc.
CMRX
| $850K | ﹤0.01% |
440,093
+14,391
| +3% | +$32.3K |
|
|
ORC
2785
Orchid Island Capital
ORC
$1.31B
| $848K | ﹤0.01% |
103,226
-1,969
| -2% | -$27.3K |
|
2786
Universal Logistics Holdings
ULH
$529M
| $846K | ﹤0.01% |
26,664
-388
| -1% | -$12.8K |
|
|
MCBC
2787
DELISTED
Macatawa Bank Corp
MCBC
| $845K | ﹤0.01% |
91,283
-2,299
| -2% | -$21.6K |
|
2788
Perella Weinberg Partners
PWP
$1.3B
| $844K | ﹤0.01% |
133,359
-12,775
| -9% | -$90.7K |
|
2789
SoundThinking
SSTI
$103M
| $841K | ﹤0.01% |
29,245
-608
| -2% | -$19.1K |
|
2790
BARK
BARK
$101M
| $839K | ﹤0.01% |
23,040
+7,050
| +44% | +$261K |
|
|
SRTA
2791
Strata Critical Medical Inc
SRTA
$512M
| $834K | ﹤0.01% |
207,073
-5,314
| -3% | -$27.3K |
|
2792
Utah Medical Products
UTMD
$225M
| $834K | ﹤0.01% |
9,774
+98
| +1% | +$8.65K |
|
2793
Rush Street Interactive
RSI
$2.88B
| $832K | ﹤0.01% |
226,110
-4,154
| -2% | -$22K |
|
2794
EverCommerce
EVCM
$1.93B
| $831K | ﹤0.01% |
76,020
-210
| -0.3% | -$2.38K |
|
2795
Red River Bancshares
RRBI
$659M
| $823K | ﹤0.01% |
16,648
-458
| -3% | -$24.1K |
|
2796
Upland Software
UPLD
$15.4M
| $823K | ﹤0.01% |
10,126
-407
| -4% | -$45K |
|
|
NETI
2797
DELISTED
Eneti Inc.
NETI
| $820K | ﹤0.01% |
122,940
+1,292
| +1% | +$9.18K |
|
2798
iRadimed
IRMD
$1.18B
| $819K | ﹤0.01% |
27,242
-1,070
| -4% | -$37.3K |
|
2799
LendingTree
TREE
$451M
| $817K | ﹤0.01% |
34,252
+345
| +1% | +$13.5K |
|
|
BGFV
2800
DELISTED
Big 5 Sporting Goods
BGFV
| $811K | ﹤0.01% |
75,503
-1,339
| -2% | -$16.2K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.